Lynn Darren D, Zukin Leonid M, Dellavalle Robert
a Department of Dermatology and.
b Department of Opthamology , Denver School of Medicine, University of Colorado , Aurora , CO , USA , and.
Cutan Ocul Toxicol. 2017 Jun;36(2):185-192. doi: 10.1080/15569527.2016.1217423. Epub 2017 Jan 17.
Diphoterine, developed by the French company Prevor, is a polyvalent, chelating, amphoteric and slightly hypertonic solution used in the management of chemical cutaneous and ocular burns. While used extensively in Europe and Canada, it is has not been approved by the United States Occupational Safety and Health Administration (OSHA) as an alternative to the water-rinse method due to a lack of evidence of its safety and efficacy on human subjects. An unbiased and extensive systematic review was undertaken in order to better understand Diphoterine's safety and efficaciousness on humans.
Review the safety and efficacy of Diphoterine for treating chemical burns of the skin and eyes in humans.
Data sources: Information sources included Pubmed, the National Library of Medicine's Medline Database and the "Publications" sections of the Prevor website. Search terms included Diphoterine, chemical burn, ocular burn and cutaneous burn.
Any study type published through a peer-reviewed journal up to May 2016 was considered eligible. Published data must have included Diphoterine in the treatment of chemical burns on the skin or eyes as well as meet other specified criteria. Acceptable studies had to use either a quantitative (e.g. number of work days lost) or qualitative (e.g. level of erythema) approach when measuring cutaneous or ocular lesion outcomes.
Independent assessment of article inclusion by two authors using predefined criteria.
Diphoterine is safe and highly effective in improving healing time, healing sequelae and pain management of chemical burns on the skin and eyes of humans. Outcomes are significantly improved when compared to water or a physiologic solution equivalent. We recommend that this product be readily available to emergency responders and companies that expose their employees to hazardous chemical substances in order to improve healing sequelae, pain management and lost work days from these types of burns.
由法国普雷沃尔公司研发的二性霉素,是一种多价、螯合、两性且略具高渗性的溶液,用于处理皮肤化学烧伤和眼部烧伤。尽管在欧洲和加拿大广泛使用,但由于缺乏其对人体安全性和有效性的证据,美国职业安全与健康管理局(OSHA)尚未批准将其作为水冲洗方法的替代方案。为了更好地了解二性霉素对人体的安全性和有效性,进行了一项公正且全面的系统评价。
综述二性霉素治疗人类皮肤和眼部化学烧伤的安全性和有效性。
数据来源:信息来源包括PubMed、美国国立医学图书馆的Medline数据库以及普雷沃尔公司网站的“出版物”板块。检索词包括二性霉素、化学烧伤、眼部烧伤和皮肤烧伤。
截至2016年5月通过同行评审期刊发表的任何研究类型均被视为合格。已发表的数据必须包括二性霉素用于治疗皮肤或眼部化学烧伤,以及符合其他特定标准。可接受的研究在测量皮肤或眼部损伤结果时必须采用定量(如损失的工作日数)或定性(如红斑程度)方法。
由两名作者使用预定义标准对文章纳入进行独立评估。
二性霉素在改善人类皮肤和眼部化学烧伤的愈合时间、愈合后遗症和疼痛管理方面是安全且高效的。与水或等效生理溶液相比,结果有显著改善。我们建议应急响应人员以及让员工接触危险化学物质的公司应随时备有该产品,以改善此类烧伤的愈合后遗症、疼痛管理和误工天数。